Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells

Carcinogenesis

Volumn 32, Issue 6, 2011, Pages 812-821

  Rodriguez, Benjamin A T ^a   Weng, Yu I ^a   Liu, Ta Ming ^a   Zuo, Tao ^a   Hsu, Pei Yin ^a   Lin, Ching Hung ^b   Cheng, Ann Lii ^b   Cui, Hengmi ^c   Yan, Pearlly S ^a   Huang, Tim H M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; DNA METHYLTRANSFERASE; ESTROGEN; HISTONE DEACETYLASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR CTCF; UNTRANSLATED RNA;

ARTICLE; BREAST CANCER; CANCER CELL; ENZYME ACTIVITY; ENZYME INHIBITION; EPIGENETICS; GENE LOCUS; GENE LOSS; GENE REPRESSION; GENE SILENCING; GENOME IMPRINTING; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 79958187564     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr017     Document Type: Article

References (48)

1. Kapranov, P. et al. (2007) RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science, 316, 1484-1488.
2. Flanagan, J. et al. (2007) An epigenetic role for noncoding RNAs and intragenic DNA methylation. Genome Biol., 8, 307.
3. Wan, L.B. et al. (2008) Regulation of imprinting in clusters: noncoding RNAs versus insulators. Adv. Genet., 61, 207-223.
4. Pandey, R.R. et al. (2008) Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell, 32, 232.
5. O'Neill, M.J. (2005) The influence of non-coding RNAs on allele-specific gene expression in mammals. Hum. Mol. Genet., 14, R113-R120.
6. Weksberg, R. et al. (2003) Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum. Mol. Genet., 12, R61-R68.
7. Mancini-DiNardo, D. et al. (2006) Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev., 20, 1268-1282.
8. Fitzpatrick, G.V. et al. (2002) Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat. Genet., 32, 426.
9. Murakami, K. et al. (2007) Suggestive evidence for chromosomal localization of non-coding RNA from imprinted LIT1. J. Hum. Genet., 52, 926-933.
10. Matsuoka, S. et al. (1996) Imprinting of the gene encoding a human cyclindependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc. Natl Acad. Sci. USA, 93, 3026-3030.
11. Diaz-Meyer, N. et al. (2003) Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith-Wiedemann syndrome. J. Med. Genet., 40, 797-801.
12. Lee, M.P. et al. (1999) Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc. Natl Acad. Sci. USA, 96, 5203-5208.
13. Scelfo, R.A. et al. (2002) Loss of methylation at chromosome 11p15.5 is common in human adult tumors. Oncogene, 21, 2564-2572.
14. Schwienbacher, C. et al. (2000) Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas. Proc. Natl Acad. Sci. USA, 97, 5445-5449.
15. Sato, N. et al. (2005) Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. Clin. Cancer Res., 11, 4681-4688.
16. Soejima, H. et al. (2004) Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Oncogene, 23, 4380-4388.
17. Du, M. et al. (2003) Insulator and silencer sequences in the imprinted region of human chromosome 11p15.5. Hum. Mol. Genet., 12, 1927-1939.
18. Fitzpatrick, G.V. et al. (2007) Allele-specific binding of CTCF to the multipartite imprinting control region KvDMR1. Mol. Cell. Biol., 27, 2636-2647.
19. Foster, J.S. et al. (2003) Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway. J. Biol. Chem., 278, 41355-41366.
20. Foster, J.S. et al. (2001) Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol. Cell. Biol., 21, 794-810.
21. Cheng, A.S.L. et al. (2008) Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res., 68, 1786-1796.
22. Carroll, J.S. et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat. Genet., 38, 1289.
23. Li, T. et al. (2008) CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop. Mol. Cell. Biol., 28, 6473-6482.
24. Kurukuti, S. et al. (2006) CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. Proc. Natl Acad. Sci. USA, 103, 10684-10689.
25. Lupien, M. et al. (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell, 132, 958-970.
26. Larson, P. et al. (2008) CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer. BMC Cancer, 8, 68.
27. Ali, I.U. et al. (1987) Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science, 238, 185-188.
28. Ito, Y. et al. (2008) Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum. Mol. Genet., 17, 2633-2643.
29. Mahmoudi, S. et al. (2009) Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol. Cell, 33, 462-471.
30. He, Y. et al. (2008) The antisense transcriptomes of human cells. Science, 322, 1855-1857.
31. Yang, X. et al. (2009) CDKN1C (p57KIP2) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. PLoS ONE, 4, e5011.
32. Vu, T.H. et al. (2010) Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells. Hum. Mol. Genet., 19, 901-919.
33. Zupkovitz, G. et al. (2006) Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol. Cell. Biol., 26, 7913-7928.
34. Chernukhin, I. et al. (2007) CTCF interacts with and recruits the largest subunit of RNA polymerase II to CTCF target sites genome-wide. Mol. Cell. Biol., 27, 1631-1648.
35. Shin, J.Y. et al. (2008) Two distinct mechanisms of silencing by the KvDMR1 imprinting control region. EMBO J., 27, 168-178.
36. Hsu, P.Y. et al. (2010) Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Res., 20, 733-744.
37. Rossignol, F. et al. (2002) Natural antisense transcripts of hypoxia-inducible factor 1alpha are detected in different normal and tumour human tissues. Gene, 299, 135-140.
38. Kiyosawa, H. et al. (2005) Disclosing hidden transcripts. mouse natural sense-antisense transcripts tend to be poly(A) negative and nuclear localized. Genome Res., 15, 463-474.
39. Chen, J. et al. (2005) Genome-wide analysis of coordinate expression and evolution of human cis-encoded sense-antisense transcripts. Trends Genet., 21, 326-329.
40. Pedone, P.V. et al. (1999) Role of histone acetylation and DNA methylation in the maintenance of the imprinted expression of the H19 and Igf2 genes. FEBS Lett., 458, 45-50.
41. Hu, J.F. et al. (2000) Allele-specific histone acetylation accompanies genomic imprinting of the insulin-like growth factor II receptor gene. Endocrinology, 141, 4428-4435.
42. El Kharroubi, A. et al. (2001) DNA demethylation reactivates a subset of imprinted genes in uniparental mouse embryonic fibroblasts. J. Biol. Chem., 276, 8674-8680.
43. Lapidot, M. et al. (2006) Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms. EMBO Rep., 7, 1216-1222.
44. Dallosso, A.R. et al. (2007) Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer. RNA., 13, 2287-2299.
45. Li, Y. et al. (2002) Aberrant DNA methylation of p57KIP2 gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood, 100, 2572-2577.
46. Shen, L. et al. (2003) Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocyticleukemia. Blood, 101, 4131-4136.
47. Kikuchi, T. et al. (2002) Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors. Oncogene, 21, 2741-2749.
48. Lodygin, D. et al. (2005) Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res., 65, 4218-4227.